Publicly-listed Isofol Medical, a biotech company developing arfolitixorin, has appointed Margareta Hagman as its new CFO, succeeding Magnus Hurst, who has been Isofol’s CFO on a consultancy basis since January…
Sweden: Hagman appointed as CFO at Isofol Medical
…
…






